Jefferies Downgrades Halozyme Therapeutics (HALO) to Underperform; FDA Orders Hold on rHuPH20 Trials
Go back to Jefferies Downgrades Halozyme Therapeutics (HALO) to Underperform; FDA Orders Hold on rHuPH20 Trials| Baxter International Inc. (NYSE: BAX) | Delayed: 25.96 -0.77 (2.88%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $26.73 | 52 Week High | $50.16 | |||
| Open | $26.47 | 52 Week Low | $34.06 | |||
| Day High | $26.47 | P/E | 7.09 | |||
| Day Low | $25.88 | EPS | $3.66 | |||
| Volume | 3,227,840 | |||||
| Halozyme Therapeutics, Inc. (NASDAQ: HALO) | Delayed: 103.46 +4.80 (4.87%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $98.66 | 52 Week High | $18.39 | |||
| Open | $98.86 | 52 Week Low | $6.96 | |||
| Day High | $104.09 | P/E | N/A | |||
| Day Low | $98.58 | EPS | $-0.58 | |||
| Volume | 1,348,152 | |||||
| Viropharma, Inc. (NASDAQ: VPHM) | Delayed: 49.96 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $49.96 | 52 Week High | $49.99 | |||
| Open | $49.96 | 52 Week Low | $23.13 | |||
| Day High | $49.96 | P/E | N/A | |||
| Day Low | $49.96 | EPS | $-0.99 | |||
| Volume | 580 | |||||
